Skip navigation

GlobeinvestorGOLD Canada's most comprehensive investment tool.

Fund Price: $35.48 (as at May 17, 2013)  1-day chg: $.16 0.45%  YTD: 24.80%

Returns as at April 30, 2013

  Fund Group Avg Index*
1 Month 2.71% 2.45% 2.45%
3 Months 9.26% 9.69% 9.81%
6 Months 25.22% 19.51% 19.46%
1 Year 40.38% 27.79% 27.54%
2 Year Avg 19.79% 14.94% 15.06%
3 Year Avg 19.78% 13.64% 13.76%
4 Year Avg 27.44% 16.19% 15.47%
5 Year Avg 11.83% 8.56% 9.15%
10 Year Avg 12.96% 6.43% 5.79%
15 Year Avg 8.70% 6.04% 1.05%
20 Year Avg - - 1.49%
Since Inception 10.38% - -
 
2012 33.77% 19.96% 17.91%
2011 -1.33% 2.29% 4.01%
2010 10.19% 3.89% 2.56%
 
3 year risk 16.81 12.70 10.25
3 year beta 1.37 1.07 1.00

*Globe Health Care Peer Index

Growth of $10,000

This graph shows how a $10,000 investment in this fund would have changed in value compared with the Globe Health Care Peer Index.

Risk Measures as at April 30, 2013

Best/Worst 12 months (since inception)
Best (ending Feb 10): 65.44 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Worst (ending Nov 08): -41.65 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
Volatility meter (Based on 3 year standard deviation from GlobeInvestor.com)
Low VOLATILITY METER: 17 High

Fund Objectives

This fund's objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio advisor believes would benefit from developments in the health sciences industry. Any change to the investment objective must be approved by a majority of votes cast at a meeting of unitholders held for that reason.

Fund Facts

Fund Sponsor: CI Investments Inc.
Managed by: CI Investments Inc.
Fund Type: MF Corp
Inception Date: July 1996
Asset Class: Health Care Equity
Quartile Rank: 1 (3YR ending April 30, 2013)
Total Assets: N/A
Mgmt Exp. Ratio (MER): 2.44%
Management Fee: 2.00%
Load Type: Optional
Globe 5-Star Rating:
RRSP Eligible:
Canadian
Min. Invest (initial):
$500
Subsequent:
$50
Min. Invest (initial RRSP):
$500
Subsequent RRSP:
$50
Closed:
No
Restricted:
No
Restriction:
 
 

Asset Allocation April 30, 2013

Equity Sector Weightings April 30, 2013

Fund Geography April 30, 2013

Top Holdings as at April 30, 2013

Symbol Company Name Sector Geographic
Area		 Asset
Type		 % of
Total Assets		   Performance as at May 17, 2013
1 Year Performance (%)
HLS-N HealthSouth Medical Services United States Stock 5.09   53.96 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
- Roche Holdings Biotechnology & Pharmaceuticals Switzerland Stock 4.61   - bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
BMRN-Q Biomarin Pharmaceuticals Biotechnology & Pharmaceuticals United States Stock 4.35   72.16 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
BSX-N Boston Scientific Biotechnology & Pharmaceuticals United States Stock 4.26   49.18 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
PTI-T Patheon Inc. Biotechnology & Pharmaceuticals Canada Stock 4.21   211.11 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
MRK-N Merck & Company Biotechnology & Pharmaceuticals United States Stock 3.9   20.93 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
NVS-N Novartis AG Biotechnology & Pharmaceuticals Switzerland Stock 3.9   43.7 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
SNY-N Sanofi Biotechnology & Pharmaceuticals France Stock 2.97   59.5 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)
AIRM-Q Air Methods Transportation United States Stock 2.93   14.03 bar graph of the performance of this holding (negative result) bar graph of the performance of this holding (positive result)

Distribution Report (18 months up to May 17, 2013)

Frequency of Income Distributions: Annually

Frequency of Capital Gain Distributions: Annually

Date Income Dividend Capital Gain Total (Current Period) Trailing 12-Months Total Reinvestment Price
Dec 14, 2012 0.2880 0.2880 0.2880 28.200
Dec 16, 2011 0.1310 0.1310 0.1310 20.350

Portfolio Manager(s)

Andrew Waight

Altrinsic Global Advisors, LLC

Start Date: June, 2000

Fund Return: 5.87%

Mr. Waight is a principal of Altrinsic Global Advisors with primary research responsibility for the global health care sector. He has specialized in global health care since 1992 and has been a portfolio manager of the CI Global Health Sciences Fund since 1999. Prior to this, Mr. Waight managed assets for BPI Mutual Funds and Mutual Asset Management. Mr. Waight holds an honors bachelor of science degree in genetics and a M.Sc. in biochemistry, both from the University of Western Ontario. Mr. Waight also holds a M.B.A. from Western and a Chartered Financial Analyst designation.

View fund manager performance report